UCT Private Academic Hospital
UCT Private Academic Hospital

+27 (0)21 442 1800

BACK TO INDEX

Novitzky Nicolas, Prof

Male
Physicians,Clinical Haematology
Novitzky Nicolas, Prof

Novitzky Nicolas, Prof

  1. Novitzky N, Thomas V, du Toit C. Conditioning with purine analogues leads to good engraftment rates of immunodepleted grafts for aplastic anemia. Biol Blood Marrow Transplant. 2013 Apr;19(4):584-8. Doi: Epub 2012 Dec 25.
  2. Novitzky N and Thomas V. In the absence of clinically significant graft vs. Host disease, myeloablative conditioning may allow an effective graft vs. Leukaemia effect. Leukemia Research 2012; January 36(1): 104-109.
  3. Novitzky N, Thomas V, Du Toit C, McDonald A. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukaemia? A retrospective analysis. Biology of Blood and Marrow Transplantation 2011; June 17(6); 875-884.
  4. Novitzky N, Thomas V, du Toit C and McDonald A. In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved. Biology of Blood and Marrow Transplantation, 14: 709-718, 2008.
  5. Novitzky N, Thomas V and Du Toit C. Prevention of graft vs. host disease with alemtuzumab ‘in the bag’ decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome. Cytotherapy, 10 (1): 45-53, 2008.
  6. Novitzky N and Thomas V. Allogeneic Stem Cell Transplantation with T-cell Depleted Grafts for Lymphoproliferative Malignancies. Biology of Blood and Marrow Transplantation, 13: 107-115, 2007.
  7. Novitzky N, Thomas V, Hale G and Waldmann H. Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts. Bone Marrow Transplantation, Vol 36, 675-682, 2005.
  8. Davison GM, Novitzky N, Kline A, Thomas V, Abrahams L, Hale G, Waldmann H. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells. Transplantation, Vol. 69 (7) : 1341-1347, April 2000.

Education

  • F.C.P. (SA), PhD
  • Specialist in Internal Medicine
  • Clinical Haematologist 

Professional membership 

  • South African Oncology Consortium (SAOC) College of Medicine of South Africa (CMSA)
  • Board of Health Funders /PCNS (BHF)
  • Health Professional Council of South Africa (HPCSA)
  • South African Society of Haematology (SASH)
  • South African Stem Cell transplantation Society (SASCeTS)
  • South African Clinical Haematology Society (SACHas)
  • Aga Khan University External Examiner
  • South African Bone Marrow Register Board Member (SABMR)

 

Tel. 021 442 1856